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Medroxyprogesterone Acetate (MPA) is birth control that is used for contraception 
and hormone therapy (Seven et al., 2014). MPA is considered to be an ideal birth control 
option for adolescents because of its convenient administration and fast onset (Rickert et al., 
2006). While there are studies that indicate detriments in spatial memory in ovariectomized 
or older rats following administration of MPA (Braden et al., 2011), there is limited research 
investigating the effects of MPA in young ovary-intact mice. The goal of this project was to 
assess if the effects of progestin previously described are apparent in an ovary-intact 
population. Behavioral assays measured anxiety-like behavior, spatial memory, and activities 
of daily living. Despite no significant findings in these measures, this study provides a 
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INTRODUCTION 
Medroxyprogesterone Acetate (MPA) is an injectable form of birth control that is 
used for contraception and hormone therapy (Seven et al., 2014). MPA contains synthetic 
progesterone, progestin. The research on progestin has not explored female mice at the 
beginning stages of sexual maturity; rather, focusing on models that have been 
ovariectomized and rats mimicking hormone therapy used during menopause. Research has 
been conducted on MPA in combination with endogenous progesterone or with equine 
estrogen (Frye, Walf, & Paris, 2010). MPA evaluated alone has only been done in 
ovariectomized rodents rather than ovary-intact rodents. MPA’s effect on cognitive function, 
specifically in the hippocampus, has not been studied at the beginning stage of sexual 
maturity. Depo-Provera has been available for contraceptive-use and hormone therapy since 
1992, yet the implications on the brain have hardly been studied. Little research has been 
done in assessing the detriments to memory in conjunction with progestin use, making more 
insight imperative.  
Importance and Use of Birth Control 
Birth control can be used for the prevention of acne, regulating or halting menstrual 
cycles, reducing pain, regulating blood flow, and for contraceptive purposes (Spencer, 
Bonnema & McNamara, 2009). In many countries, there has been an increased use of birth 
control (Sámano et al., 2019). There is a negative social stigma attached to young girls 
becoming pregnant and there is a financial cost associated with a pregnant child that can 
hinder the family unit’s economic bearings (Klepinger, Lundberg & Plotnick, 1999).  
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Additionally, pregnant young girls are unlikely to succeed academically and face an 
increased high school dropout rate than their non-pregnant counterparts (Klepinger, 
Lundberg & Plotnick, 1999). 
However, there is little research investigating the effect of contraceptives on health in 
young girls (Chandra-Mouli et al., 2017). Depo-Provera, a contraceptive containing MPA, 
has been examined as an ideal form of birth control for adolescent girls due to its 
convenience and fast onset (Rickert et al., 2006). While Depo-Provera seems to be an 
advantageous tool for adolescent girls, there is little research on how MPA affects the brain; 
specifically in regard to learning and memory.  
Medroxyprogesterone Acetate 
Depo-Provera is commonly prescribed for contraception or hormone therapy in 
women (Westhoff, 2003). Depo-Provera does not contain estrogen; rather, progestin is the 
only hormonal ingredient. Progestin is the exogenous, not naturally produced, form of 
progesterone which is a sex hormone essential for menstruation and pregnancy. Some 
women may have complications with estrogen infused with other contraceptives such as, a 
transdermal patch, intravaginal ring, or various oral contraceptives, making the singular 
hormonal ingredient of Depo-Provera, progestin, more accommodating (Spencer, Bonnema 
& McNamara, 2009). Some women who are breastfeeding fall under these circumstances. 
Depo-Provera is administered intramuscularly or subcutaneously every three months through 
the deltoid or gluteal muscle or under the skin at the upper arm (Spencer et al., 2009). This 
three-month administration regimen is appealing for many women in comparison to daily  
oral contraceptives (Spencer et al., 2009). Women report amenorrhea, or loss of menstrual  
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cycle, after the second dose. Additionally, after ten months of cessation, fertility may resume. 
While Depo-Provera does not protect against sexually transmitted diseases or infections, the 
chances of becoming pregnant while adhering to proper administration is 0.3% (Spencer et. 
al., 2009).   
Side Effects 
There are several potential negative side-effects/risks from taking Depo-Provera. A 
common risk associated with Depo-Provera is the loss of bone mineral density which some 
studies have shown lead to a reversal after cessation of use (American College of 
Obstetricians and Gynecologists [ACOG], 2014). However, health professionals suggest that 
women only use Depo-Provera for up to two years to reduce the risk of fractures. Weight 
gain is often associated with contraceptive use and depression can also be exacerbated with 
the use of hormonal contraceptives (ACOG, 2014). As previously mentioned, amenorrhea is 
common with Depo-Provera making detecting pregnancy difficult. The association between 
memory impairment and progestin has only begun to be investigated. Additionally, MPA has 
been shown to have implications on anxiety and impact quality of life (Wershler, 2004).  
Involvement of the Brain 
There are numerous regions of the brain associated with memory; however, the 
hippocampus is one of the most prominent, being an essential component to long-term and 
spatial memory (Shrager, Bayley, Bontempi, Hopkins & Squire, 2007). The progestin in 
MPA appears to negatively affect the hippocampus (Ciriza, Carrero, Frye & Garcia-Segura, 
2006), a brain structure critical in learning and memory; most notably, spatial memory. 
Spatial memory in the hippocampus works by exciting neurons according to environmental  
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cues (Shrager et. al., 2007). The cells that initiate the action potential of the neurons in 
response to spatial memory comprise several areas of the brain, however, they are more 
concentrated in and around the hippocampus (Kentros, 2006). Research on Depo-Provera, a 
synthetic progestin, on ovary-intact young female mice has not been done. However, 
research has investigated this paradigm in ovariectomized rats and found impairment in 
cognitive tasks (Braden et. al., 2007; Frye, Koonce & Walf, 2013). 
 Hippocampal-dependent memory has been assessed with progestin in combination 
with other estrogen, oestradiol, and progesterone derivatives utilized in hormone treatments 
(Chan et. al., 2014; Chislom & Juraska, 2012; Lewis et. al., 2008). These combinations of 
hormones describe the synergistic effects of several hormone treatments. Indeed, progestin’s  
effects on learning and memory have not been assessed in young female rodents and 
necessitates investigation.  
Previous Research 
The research methods of the available studies are limited as well, with many tests 
being repeated in each study. In rodent models, tests that evaluate spatial memory include: 
the Barnes maze, Morris water maze (MWM), and the radial arm maze. Current literature 
assessing spatial memory and progestin utilize the radial arm maze and the MWM (Bimonte 
et al., 2000; Braden et al., 2011). These mazes use visual cues which allow the rodents to 
locate a hidden platform (Bimonte, et al., 2000; Morris et. al., 1982) and assess an animal’s 
ability to learn its location over a period of time. Additional research assessing progestin’s 
effects on memory utilizing biological testing is limited and inconsistent as well. Other 
measures outside of memory have not been examined. Activities of daily living have not 
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been previously studied with the effects of MPA and is therefore, warranted.  
Based on the available research, a few inferences can be drawn pertaining to the 
effects of progestin on the hippocampus. MPA has been found to work against estrogen’s 
neuroprotective and memory functioning (Song et al., 2020). In particular, this antagonistic 
effect caused by MPA is concentrated in the hippocampus. (Nilsen & Brinton, 2002). These 
findings support Depo-Provera’s role in cognitive decline in the hippocampus and 
hippocampal-dependent tasks.  
Purpose/Hypothesis 
The goal of this project was to assess if the effects of progestin previously described 
are apparent in an ovary-intact population. Behavioral assays used measured hippocampal-
dependent memory (Morris Water Maze) (Morris, Garrud, Rawlins & O’Keefe, 1982) 
anxiety (Elevated Zero Maze and Open Field), and activities of daily living (Burrowing and 
Nesting). The main hypothesis was that female mice given MPA would do worse than those 
not receiving MPA in each behavioral test including the open-field test, elevated zero maze, 
MWM, and in activities of daily living. Additionally, it was hypothesized that those mice that 
began with MPA and were switched to vehicle injections would have worse learning and 
memory deficits than the control mice. In the present study, the goal was to administer MPA 
to ovary-intact mice starting roughly during adolescence through young adulthood and assess 




Forty-eight adolescent female mice (C57BL/6J), aged 21 days, were purchased from 
the Jackson Laboratory (Jax, Bar Harbor, ME). Upon arrival at the psychology lab vivarium, 
the animals were group housed three to a cage in an Animal Care Systems Optirat© rodent 
caging system and provided ad libitum access to food and water. The lab was maintained on 
a 12-hour light/dark cycle. The mice were ear punched at 4 weeks old for identification 
purposes. Animals were routinely handled twice a week so that they became used to human 
touch.  
This study was done utilizing two cohorts separated by two weeks. The use of two 
cohorts allowed researchers to avoid running 48 mice at a time during behavioral testing, 
eliminating the need to run behavioral tests for an extended time. There was a total of 48 
mice being used in this study, however, two mice died prior to behavioral testing. In each 
cohort, there was 24 mice. Following the acclimation period, animals were randomly 
assigned to one of four treatment groups: control (n=11), MPA (n=12), MPA Cessation 
(n=12), and MPA Delayed (n=11). (as described below). The same schedule and testing were 
done with each cohort; with the exception of the Morris Water Maze for the second cohort. 
Due to the University’s Coronavirus (Covid-19) response and a SMART video tracking 
software malfunction, MWM data was unable to be collected for the second cohort.  
Drug Conditions 
When mice were 6 weeks old, each treatment group began to receive weekly 




mouse was collected to ensure that each mouse received the correct dosage. The back of the 
neck was pulled with two fingers creating a space for the injection to occur. The dosage 
utilized in this study follows previous research that has been shown to have anti-ovulatory 
effects (Braden et. al, 2011; Bhowmik and Mukherjea, 1988). The control group received 6 
weeks of continuous vehicle injections (0.4 ml Sesame Oil + 0.02 ml DMSO/ kg). The MPA 
group received 6 weeks of continuous MPA injections (3.5mg MPA + 0.4ml Sesame Oil + 
0.02 ml DMSO/ kg). The MPA Cessation group received 3 weeks of MPA injections, 
followed by 3 weeks of vehicle injections. The MPA Delayed group received 3 weeks of 
vehicle injections, followed by 3 weeks of MPA injections. Sesame oil, DMSO, and MPA 
were purchased from Sigma-Aldrich, St. Louis, MO, USA. 
Body Weight 
 The mice were weighed the day before injections, at the same time, in grams. This 
ensured that each mouse was given the correct dosage according to their weight. This value 
was converted to kg for purposes of injections. Additionally, body weight was collected over 
the length of the experiment (9 weeks) to determine if MPA had an impact on weight gain as 
birth control has been shown to impact weight (Lange, 2015).  
Behavioral Measures 
Open-Field Test  
The open field test is a measure of innate exploratory behavior and is commonly used 
as a “control” assay for other behavioral tests that involve activity. The open field test can 
also measure anxiety-like behavior in mice by measuring how much time is spent in the 
surround or edges of the box compared to the time spent in the center of the box. The mouse  
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was placed into a novel white box measuring 45cm x 45cm without any type of extraneous 
stimuli and was allowed to explore for 5 minutes. Animals were gently placed in the 
apparatus, facing a wall, and activity was recorded over a 5-minute period using the SMART 
video tracking system (Panlab, Harvard Apparatus). Data collected included: latency (s) to 
first enter the center of the OF, time (s) spent in the surround and center, and distance 
travelled throughout the single trial. The open field box was thoroughly cleaned with 70% 
ethanol between each mouse to reduce olfactory cues.  
Elevated Zero Maze 
The elevated zero maze (EZM) is a test that measures anxiety and risk-taking 
behavior. The apparatus is an “O” shaped platform that is raised above the ground and is 
divided into two sections with walls surrounding the edges and two open sections with no 
surrounding walls. The EZM has two open portions and two closed portions; in addition, the 
EZM does not have the middle intersection, forcing the mouse to either be in an open or a 
closed section at any given time. Being in a portion of the maze was operationally defined as 
having all 4 paws being in that area. Each animal was given a single trial that began with the 
mouse being placed in a closed portion of the maze facing inward. Once the animal was 
placed, data was collected for one, 5-minute trial. SMART video tracking software (Panlab, 
Harvard Apparatus) recorded the 5-minute trial allowing the researcher to measure the time 
(s) spent in each section of the maze (open v. closed), the total number of entries into each 
section, and the latency to first enter an open arm. In addition, the number of head dips that 
the mice made were recorded. Head dips were counted when the mouse looked over the edge  
of the open arm. The maze was wiped down with 70% ethanol to reduce olfactory cues  
9 
between animals upon completion of each animal’s single trial. 
Morris Water Maze 
The Morris Water Maze (MWM) is commonly used in the literature assessing MPA 
and spatial memory (Braden et al., 2011; Lewis et al., 2008). The MWM task is used to 
assess spatial memory in rodents and relies on the hippocampus. Animals learn to locate a 
clear platform hidden just below water (~ 5-10mm) to allow them to escape the water.  
MWM testing took place over 6 consecutive days with 4 trials per day, except for days 5 and 
6 which consisted of only 1 and 2 trials, respectively.  The MWM tub was filled with opaque 
water (water made opaque through the addition of non-toxic white paint) to keep the animals 
from seeing the platform. Visual cues were black and white images located around the tub, 
which was surrounded by a white curtain (approximately 12 inches away from the tub). Each 
mouse was placed in the tub facing the wall. The submerged escape platform was in a fixed 
location for the trials but where the animal started changed for each trial, forcing them to use 
the cues around the pool to recall the where the platform was located. The mice were given 
60 seconds to find the hidden platform while being tracked by an overhead camera (using the 
SMART Video tracking system (Panlab), Harvard Apparatus). Distance traveled in inches, 
latency to find the platform, and percent time spent in the target quadrant were measured. In 
addition, thigmotaxicity was measured, a measurement of how much time the mouse spent in 
the outer edges of the pool, which is an indicator of anxiety-like behavior. At the end of the 
60 second trial, if a mouse failed to find the platform, the mouse was gently guided to the 
platform where it remained for 10 seconds before being removed. Upon completion of the  
trial, the animal was dried with a towel and placed under a heating lamp for 45 seconds  
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before beginning the next trial (45 second intertrial interval). Once the animal had completed 
all 4 trials, it was finished for the day.  
On days 2 and 4, the last trial was a probe trial; this consisted of the platform being 
lowered so that the animal was unable to climb onto it. The mice were given 60 seconds 
before the platform was raised and they were guided to it. The purpose of the probe trial was 
to measure the amount of time the animal spent searching in the target quadrant where the 
platform was located; in addition, crosses over where the platform would normally be was 
measured. The more time spent in the target quadrant suggests that the animal remembers 
where the platform would normally be.   
Day 5 consisted of a single trial which was a probe trial. This trial was used to assess 
long-term memory of the platform’s location; additionally, platform crosses was recorded.  
Day 6 consisted of 2 trials using a visual platform to ensure there were no visual 
abnormalities. This involved moving the platform to a different quadrant and raising the 
platform above the water with a large blue Lego block to attract visual attention in a different 
quadrant than it normally was placed in. This was to assess whether mice could see the 
platform and rule out any visual deficits.  
Activities of Daily Living 
Burrowing 
Burrowing is an innate behavior in mice that provides shelter (Deacon, 2006). The 
burrowing test is relatively easy to set up and allows a quick assessment of a behavior 
which may point toward neurological deficits, specifically deficits in activities of daily 
living. This assessment was done at 5PM, so that a preliminary assessment of burrowing  
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was made an hour before lights go out in the facility (7PM). A hollow tube (PVC pipe) with 
one end closed was filled with 250 grams of pea-gravel (small rocks) and weighed after a 
mouse had interacted with it for 2 hours and was weighed again the following morning. In 
order to perform the burrowing assay, each mouse was individually housed for a period of 
less than 24 hours. The next morning, the tubes were weighed again. No additional stimuli 
were added to the cage. 
Nesting 
Nesting is a simple measure of activities of daily living in mice. For nesting, the cage was 
filled with corn cob bedding (enough to cover the bottom of the cage) and 3.5 grams of 
shredded white paper were scattered around the bottom. Nests were scored on a 1-5 scale by 
trained raters who were uninformed to treatment condition with the following scale:  
• 1-the shredded paper appears to be untouched 
• 2-there was some attempt to build a nest, but the majority of paper is still 
scattered throughout the cage 
• 3-a nest was somewhat constructed using a majority of the paper but there still 
shredding remains around the cage 
• 4-a nest was constructed with only minimal paper not incorporated 
• 5-all of the paper has been used in the building of the nest.  
Raters scored the nests after all testing and euthanasia was completed and inter-rater 
reliability was measured. Raters were shown pictures of nests to train them on how to  
recognize nest scores; each rater rated nests individually. Rating was accomplished by 
showing raters pictures of the nests that were built and then the raters scored each nest  
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individually. The raters did not come into contact with the mice while they were in the 
nesting assay. Animals were separately housed in cages for the duration of the nesting 
experiment. They had to be housed separately so that nest building ability could be 
accurately assessed. After nesting was complete, animals were placed back into their home 
cage. 
Statistical Analysis 
After the data were collected, each behavioral test was analyzed separately. A mixed 
ANOVA was run for body weight; time was the within-subject factor and treatment group 
the between-subject factor. For the open-field test, elevated zero maze, and activities of daily 
living (burrowing and nesting), a one-way ANOVA was conducted (factor being drug 
administration with 4 levels). Morris Water Maze data was analyzed using a mixed ANOVA 
with experimental groups (between-subjects variable) and days (within-subject variable) as 




 A mixed ANOVA was conducted weekly body weight to assess differences between 
treatment groups. There was a significant within-subject effect on weekly body weight, F 
(4.06, 170.38) = 364.49, p < .01. These results indicate that as time increased, body weight 
increased. There was no difference in weight between treatment groups. (Figure 1). 
 
Figure 1. The mice in all treatment groups gained a significant amount of weight over nine 
weeks. 
 
Open Field Test 
Latency (s) to first enter the center of the OF 
 There was no significant difference in treatment group on latency to enter the center 
of the open field, F (3,42) = .32, p = .81. 
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Time spent in the surround and center 
There was no significant difference in either percent time spent in the surround, F (3, 
42) = .59, p = .69 or the center, F (3, 42) = .54, p = .66 between treatment conditions.  
Distance travelled throughout the single trial  
There was no significant difference between treatment groups in the total distance 
traveled in the open field task, F (3,42) = .83, p =.49. 
Elevated Zero Maze 
Latency to the Open Arm 
There was no significant difference between treatment groups in the latency to enter 
an open arm, F (3,42) = .58, p = .63. 
Time Spent in the Open Arm 
There was no significant difference between treatment groups in the time spent in the  
open arms, F (3,42) = 2.32, p = .09. However, mice given MPA or those that received MPA 
during the last half of doses spent, on average, more time in the open arm (Table 1). 
Treatment Group Mean Standard Error Lower Bound Upper Bound 
MPA 8.348 1.393 5.538 11.159 
Vehicle 5.187 1.455 2.252 8.123 
Cessation 4.224 1.393 1.413 7.035 
Delayed 8.400 1.455 5.465 11.336 
 
Table 1. The mice in the MPA and MPA Delayed treatment group spent more time in the 
open arm of the EZM compared to the vehicle and MPA cessation treatment group. 
 
Number of Entries into a New Arm  
There was no significant difference between treatment groups in the number of 
entries into a new arm, F (3,42) = 1.96, p = .14. 
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Head Dips 
There was no significant difference between treatment groups in the amount of head 
dips, F (3,42) = 2.26, p = .10. 
Morris Water Maze 
A mixed ANOVA was run for all variables assessed in the MWM. 
Thigmotaxicity 
 There was a significant within-subjects effect days on thigmotaxicity, F (2.001, 
36.022) = 55.48, p < .01. These results indicate that as the days progressed, the mice spent 
significantly less time around the border of the pool, signaling that the mice showed less 
anxiety over time. There was no significant difference between treatment groups (Figure 2). 
 
Figure 2. Thigmotaxicity is the percent time spent in the surround in the tub, which is 
indicative of anxiety-like behavior. 
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Time Spent in Target Quadrant 
 There was a significant within-subjects effect for percent time spent in the target 
quadrant, F (1.81, 5.44) = 65.097, p < .05.  As the days progressed, the mice spent 
significantly more percent time in the target quadrant, showing that the mice were retaining  
the spatial information directing the mice to the target quadrant. There was no significant 
difference between treatment groups (Figure 3).  
 
Figure 3. Time spent in the target quadrant, the quadrant where the platform is located, on 
day five (probe day) by treatment group. 
 
Target Crosses 
There was no significant difference between treatment groups for target crosses on 
day five, F (3,18) = .62, p = .61.  
Latency to Target  
 There was a significant within-subjects effect on latency to reach the target platform, 
F (2, 36) = 5.63, p < .01. These results indicate that as the days progressed, the mice  
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decreased the time spent finding the target, signaling that the mice learned over time. (Figure 
4). There was no significant difference between treatment groups for latency to reach the 
target.  
 
Figure 4. The time it took for the mice to find the platform on days two, three, and four by 
treatment group. 
 
Assessing Visual Abnormalities 
There were no differences between groups to locate the platform during the visual cue 
day indicating that there were no visual abnormalities, F (3, 18) = .196, p= .898 
Activities of Daily Living 
Burrowing Behavior 
There was no significant difference between treatment groups in the amount of pea 
gravel burrowed at 2hrs, F (3,42) = .66, p = .58 nor overnight, F (3, 41) = 1.34, p = .27. 
Nesting 
There was no significant difference between treatment groups for nests built, F (3,42) 
= .144, p = .93. All mice built highly rated nests, regardless of their treatment group (Figure  
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5). Cronbach’s alpha was run to determine if there was agreement between the raters; there 
was an acceptable agreement between the two raters, α = .76.  
 
Figure 5., Nesting. Mouse 16 from the MPA treatment group was given a score of “4” was 
given to this mouse’s nest, while Mouse 7 from the Delayed treatment group was given a 











     
DISCUSSION 
The purpose of this study was to examine the influence of Depo-Provera on weight 
gain, anxiety, learning, and activities of daily living in ovary-intact mice during adolescence. 
The study did not find any effect of Depo-Provera on any of the behavioral assays 
administered nor on weight gain. The current study’s findings did not match previous 
findings in other studies that assessed MPA. However, these studies utilized MPA either in 
conjunction with other hormones, were administered at a later age, or were given in 
ovariectomized rodents.  
Experimental Methods 
Body Weights 
 There were no significant differences in body weights amongst treatment groups, 
which does not match previous findings in human studies (Oshodi et al., 2019). In humans, 
females on Depo-Provera have experienced an increase in body mass, however, with the use 
of Depo-Provera an increase of dietary intake is also apparent (Lange et al., 2015). In this 
study, food was given ad libitum and the amount of food consumed was not measured. 
Perhaps in this study, the mice consumed food in equal portions. Researchers should consider 
dietary intake when measuring the effects of MPA or other forms of birth control in rodents. 
Open Field Test and Elevated Zero Maze 
 The results from the open field test and the elevated zero maze did not support the 
predicted hypotheses. There have not been previous studies assessing MPA’s effect on 
anxiety-like behavior. The current study indicated that MPA did not impact anxiety-like 
behavior. This aligns with studies done in humans assessing the influence of Depo-Provera  
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and anxiety in women who were not predisposed to anxiety disorders (Hall et al., 2015; 
Westhoff et al., 1998). Additionally, the mice were handled frequently as a form of 
habituation and while receiving weekly injections; this may have resulted in a decrease in 
stress and in turn translated into a decrease in anxiety-like behavior. Similar to the open field 
test, the elevated mero maze assesses anxiety-like behavior. The current study did not find an 
effect of MPA on risk-taking behavior and anxiety-like behavior, which did not support the 
hypothesis. 
Morris Water Maze 
The Morris Water Maze results did not support the hypothesis. In the MWM, the only 
significant results were found in thigmotaxicity and latency to target demonstrating the effect 
of learning over days, however, there was not any significant difference between treatment 
groups. The results from this study did not align with previous findings regarding the use of 
MPA. However, in a study assessing oral contraceptives and verbal learning in humans, oral 
contraceptives actually aided in learning (Pletzer & Kerschbaum, 2014), so it is possible that 
birth control, including MPA, can aid in cognitive tasks. Additionally, other studies 
predominately used ovariectomized (Braden et al., 2011) or middle-aged rats (Chisholm & 
Juraska, 2011) rather than ovary-intact animals. Other studies found that MPA use alone 
impairs hippocampal-dependent tasks such as the Radial Arm Maze (Braden et al., 2011). No 
significant differences in the MWM could have occurred due to the low sample size or the 
duration of MPA administration. In this study, however, there were trending data. These data 
perhaps may have been significant if the sample size were to have increased by utilizing the 
second cohort as intended. 
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Activities of Daily Living 
 There were no significant differences found amongst any of the groups, indicating 
that innate behavior was not impacted by MPA. There have not been previous studies 
utilizing activities of daily living corresponding with the use of MPA. It would be ideal to 
utilize activities of daily living in rodents that are ovariectomized or in later stages of life, 
especially to assess MPA use in later life or in cases of neurodegenerative disease such as 
Alzheimer’s disease. In later life, females’ estrogen levels diminish, affecting the 
neuroprotective effects associated with estrogen (Nilsen & Brinton, 2002), which is believed 
to contribute to the disproportionately higher rates of Alzheimer’s disease in women than 
men (Pike, 2017). MPA is often utilized in conjunction with other hormones for hormone 
treatment to treat menopause symptoms, so it would be vital to see if MPA has an impact on 
activities of daily living in an older population with a decreased level of estrogen. 
Limitations 
 Limitations in this study predominately affected the Morris Water Maze results. 
Specifically, in the first day of the first cohort of the Morris Water Maze, thigmotaxicity and 
latency to the platform could not be included for analysis due to these variables not being 
recorded. This was due to a computer error. Another limitation in this study was the Morris 
Water Maze data from the second cohort was not included for analysis due to a malfunction 
in the SMART system’s tracking along with restricted access to campus due to the 
Coronavirus (Covid-19) pandemic. The Morris Water Maze was the only hippocampal-




 The analysis of brain regions such as the hippocampus and the amygdala could 
further describe the relationship between MPA, learning, and anxiety. While this study did 
not find negative effects of MPA on behavior, brain regions may be affected prior to 
influencing behavior.  
 Future studies could lengthen the timeline of injections to ensure drug efficacy and to 
clarify the effects of long-term use. Additionally, different time points could be assessed. For 
example, MPA could be administered at the beginning of sexual maturity, as done in this 
study, in mid-adulthood, and during late adulthood.  
 Further investigation is needed across different age populations and across different 
time points regarding the contraceptive use of MPA. These studies should conduct more 
behavioral tests to capture a more in-depth analysis. For example, in this study, the Morris 
Water Maze was the only learning and memory assessment given. Other studies could 
include the Radial Arm Maze or Barnes Maze to assess spatial memory. In regard to body 
weight, the amount of food consumed could be an important variable to consider; 
additionally, body composition could be measured as well. Body composition analysis, 
examining the proportion of skeletal, muscular, or adipose tissue, would determine how 
MPA is impacting the body. Additionally, measuring particular hormone levels such as 
cortisol would aid in establishing whether a relationship exists between anxiety and MPA.  
  
CONCLUSION 
 Birth control has many uses. Depo-Provera is prescribed to many patients for various 
reasons, and there has been an uptake in adolescent girls being prescribed Depo-Provera. 
However, with an increase of use during a developmental time period, research needs to be 
done to investigate the impact it has on learning and memory. The findings in the current 
study did not find any impact of MPA on weight gain, anxiety, or learning and memory. 
These results did not align with previous studies examining MPA perhaps due to increase 
rodent handling throughout the weekly injections and a low sample size in the MWM. More 
research is needed in this area, so that women can make a more informative decision about 
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